A carregar...
Hydroxychloroquine, COVID‐19 and diabetes. Why it is a different story
Hydroxychloroquine has been proposed for the cure of the COVID‐19 due to its anti‐inflammatory and anti‐viral action. People with diabetes are more prone to severe outcome if affected by COVID‐19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxych...
Na minha lista:
| Publicado no: | Diabetes Metab Res Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362015/ https://ncbi.nlm.nih.gov/pubmed/32592507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.3379 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|